quinidine has been researched along with epirubicin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bedenne, L; Caillot, D; Chauffert, B; Corda, C; Martin, F; Pelletier, H; Solary, E | 1 |
| Harnett, AN; Jones, RD; Kaye, SB; Kerr, DJ; Rankin, EM; Ray, S | 1 |
| Mross, K | 1 |
| Bissett, D; Habeshaw, T; Harnett, A; Jodrell, D; Kerr, DJ; Leonard, RC; Macham, MA; Paul, J; Soukop, M; Wishart, GC | 1 |
| Bicknell, SR; Hamilton, T; Kaye, SB; Morrison, JG; Plumb, JA; Setanoians, A; Wishart, GC | 1 |
| Abad, A; Antón, A; Aranda, E; Ariza, A; Blanco, E; Carrato, A; Cervantes, A; Dorta, J; Garcia de Paredes, ML; Massuti, B; Maurel, J; Vicent, JM | 1 |
1 review(s) available for quinidine and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for quinidine and epirubicin
| Article | Year |
|---|---|
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.
Topics: Adult; Aged; Breast Neoplasms; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Epirubicin; Female; Humans; Middle Aged; Proportional Hazards Models; Quinidine; Remission Induction; Scotland; Survival Rate | 1994 |
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Quinidine; Survival Analysis; Tumor Suppressor Protein p53 | 1998 |
10 other study(ies) available for quinidine and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Colonic Neoplasms; Drug Resistance; Drug Synergism; Epirubicin; In Vitro Techniques; Quinidine; Quinine; Rats; Verapamil | 1990 |
A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; Female; Humans; Leukocyte Count; Middle Aged; Pilot Projects; Platelet Count; Quinidine | 1990 |
Multidrug-resistance modulation in metastatic breast cancer patients.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Epirubicin; Humans; Quinidine; Randomized Controlled Trials as Topic | 1995 |
Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft.
Topics: Animals; Calcium Channel Blockers; Doxorubicin; Drug Resistance; Drug Synergism; Epirubicin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Propylamines; Quinidine; Tumor Cells, Cultured; Verapamil | 1994 |